At sites of chronic inflammation epithelial cells undergo aberrant DNA methylation that contributes to tumorigenesis. Inflammation is associated with an increase in reactive oxygen species (ROS) that cause oxidative DNA damage, which has also been linked to epigenetic alterations. We previously demonstrated that in response to ROS, mismatch repair proteins MSH2 and MSH6 recruit epigenetic silencing proteins DNA methyltransferase 1 (DNMT1) and polycomb repressive complex 2 (PRC2) members to sites of DNA damage, resulting in transcriptional repression of tumor suppressor genes (TSGs). However, it was unclear what signal is unique to ROS that results in the chromatin binding of MSH2 and MSH6. Herein, we demonstrate that in response to hydrogen peroxide (H 2 O 2 ), JAK2 localizes to the nucleus and interacts with MSH2 and MSH6. Inhibition or knockdown of JAK2 reduces the H 2 O 2 -induced chromatin interaction of MSH2, MSH6, DNMT1, and PRC2 members, reduces H 2 O 2 -induced global increase in trimethylation of lysine 27 of histone H3 (H3K27me3), and abrogates oxidative damageinduced transcriptional repression of candidate TSGs. Moreover, JAK2 mRNA expression is associated with CpG island methylator phenotype (CIMP) status in human colorectal cancer. Our findings provide novel insight into the connection between kinase activation and epigenetic alterations during oxidative damage and inflammation. Environ. Mol. Mutagen. 60:308-319, 2019.
INTRODUCTION
Chronic inflammation and the associated reactive oxygen species (ROS) play an important role in the initiation and progression of many human epithelial cancers (Ding et al., 2017) . Aberrant silencing of key genes by promoter CpG island DNA hypermethylation and repressive histone modifications occurs in many cancers that form at sites of chronic inflammation (Takeshima et al., 2015; Kondo, 2009 ). Yet, the role inflammation plays in initiating these aberrant epigenetic alterations is not completely understood.
Epigenetic alterations cause mitotically heritable changes in gene expression without altering the DNA sequence. Aberrant epigenetic alterations promote the progression of cancer by altering the expression pattern of key tumor-related genes (Sharma et al., 2010) . DNA hypermethylation of promoter CpG islands impairs transcription factor binding and thereby decreases gene expression. Posttranslational modification of histone tails alters gene expression by regulating chromatin structure or recruitment of additional histone modifiers and/or readers. During chromatin-based processes such as transcription, DNA replication, and DNA repair, chromatin is modified by histone modifying enzymes, chromatin remodelers and DNA methyltransferases (Bannister and Kouzarides, 2011) . For instance, polycomb repressive complex 2 (PRC), which includes enhancer of zeste homolog 2 (EZH2), suppressor of zeste 12 protein homolog (SUZ12), and embryonic ectoderm development protein (EED), and induces trimethylation of histone H3 at Lysine 27 (H3K27me3), contributes to the formation of a repressive chromatin state and transient transcriptional inhibition at sites of oxidative DNA damage (O'Hagan et al., 2011) . DNA methyltransferase 1 (DNMT1) methylates newly synthesized DNA during DNA replication and participates in maintaining epigenetic silencing of key genes implicated in human cancers (Robert et al., 2003) .
The recruitment of DNA repair and epigenetic silencing proteins to promoter CpG islands in response to ROS may be important for initiating aberrant DNA methylation. Guanine residues in DNA are a primary target for ROS during inflammation, with 8-oxo-G being the most abundant form of oxidative damage (Ba et al., 2014) . Due to high guanine content, promoter CpG islands are hotspots for 8-oxo-G and therefore oxidative DNA damage. 8-oxo-G lesions are repaired by base excision repair (David et al., 2007) and noncanonical MMR (Zlatanou et al., 2011) pathways. We have shown that MMR proteins MSH2 and MSH6 have an increase in affinity for chromatin after 30 min of H 2 O 2 treatment (Ding et al., 2016) . MSH2 and MSH6 recruit epigenetic silencing proteins DNMT1 and EZH2 to sites of oxidative damage through a protein-protein interactiondependent mechanism (Ding et al., 2016) . In vitro and in vivo, we have demonstrated that the recruitment of DNMT1 and EZH2 to sites of oxidative DNA damage results in increased H3K27me3 deposition in the promoters of candidate TSGs that is associated with decreased gene expression (O'Hagan et al., 2011; Maiuri et al., 2017) . In vivo, this early recruitment to sites of oxidative damage results in sustained DNA hypermethylation of the TSGs' promoter CpG islands in tumors that form as a result of chronic inflammation . These findings are congruent with the knowledge that cancer-specific aberrant gains in DNA methylation tend to occur at gene promoters enriched for H3K27me3 (Schlesinger et al., 2007; Rose and Klose, 2014) . However, the upstream mechanism for increased affinity of MSH2 and MSH6 for sites of oxidative DNA damage is still unclear.
The tyrosine kinase, Janus kinase 2 (JAK2), plays important roles during the inflammatory response (Boland et al., 2014) , carcinogenesis (Du et al., 2012) , DNA damage and repair (Gloc et al., 2002; Scott and Rebel, 2012) , and may regulate epigenetic alterations (Dawson et al., 2009) . Canonical activation of JAK2 occurs in response to binding of various ligands such as interleukin-6 (IL-6) and growth hormones to the receptor to which JAK2 is bound. In this canonical response, activated JAK2 phosphorylates its downstream effector-Signal transducer and activator of transcription 3 (STAT3), which initiates transcription of genes associated with cell proliferation, differentiation and oncogenesis (Wang and Sun, 2014) . In contrast, ROS induces JAK2 signaling activation in a ligand-independent fashion (Duan et al., 2013) . In addition, ROS reduces STAT3 binding to its canonical binding targets such as consensus serum-inducible elements (SIE) and diminishes IL-6-mediated gene transcription (Li et al., 2010; Scott and Rebel, 2012; Sobotta et al., 2015) . These results suggest gene activation by the canonical JAK2 pathway and by the ROS-mediated pathway may be different. Mutant JAK2, which is constitutively active, also has noncanonical roles. Mutant JAK2 V617F can be localized in the nucleus, directly phosphorylate histone H3 at Y41, and regulate gene expression independently of ligand-activation or STAT3-interaction (Dawson et al., 2009) .
Herein, we connect JAK2 to the MMR and epigenetic response to oxidative damage. We uniquely demonstrate that active wildtype JAK2 translocates to the nucleus in response to oxidative damage and that nuclear JAK2 plays a critical role in regulating MSH2, MSH6, DNMT1 and EZH2 chromatin binding, and global levels of H3K27me3. We further show that JAK2 is important for oxidative damage-induced transcriptional repression of candidate TSGs in colon cancer cells. Understanding the connection between JAK2, MSH2, MSH6, and epigenetic alterations will provide key insight into how aberrant epigenetic alterations are initiated during chronic inflammation.
MATERIALS AND METHODS

Cell Culture and Treatments
NCCIT and SW480 cells were purchased from American Tissue Type Culture Collection (ATCC) and maintained in RPMI 1640 and McCoy's 5A media (Corning, PA), respectively with 10% fetal bovine serum (Gibco, MA). H 2 O 2 treatment was performed as previously described (Ding et al., 2016) . Tyrphostin AG490 (Sigma, MO, T3434-5MG) was dissolved in DMSO (Sigma, MO) and further diluted before adding it to the media. Cells were treated with 100 μM Tyrphostin AG490 for 6 h prior to H 2 O 2 exposure. BMS-911543 (Biovision, CA, 2630-5) was dissolved in DMSO (Sigma, MO) and further diluted before adding it to the media. Cells were treated with 2.2 nM BMS-911543 for 6 h prior to H 2 O 2 exposure.
shRNA Knockdown
For shRNA knockdown of JAK2 and Nontarget (NT), cells were infected with lentiviral particles for 96 h with puromycin (Sigma, MO) selection before collection following the manufacturer's protocol (Sigma, MO). JAK2 (Sigma, MO, SHCLNG-NM_004972, TRCN000002181) and TRC2 (NT; Sigma, MO, SHC201) were expressed using lentiviral particles following the lentiviral shRNA knockdown protocol from The RNAi Consortium Broad Institute. These assays were performed as previously described (Ding et al., 2016) . Band densitometry for western blots were measured by Image J software (NIH). Band densitometry were first normalized to LaminB or H3 and then relative densitometry of proteins across treatments was normalized to the untreated condition.
Antibodies
Immunofluorescence and Co-IP
Immunofluorescence was performed with or without preextraction buffer as indicated. Immunofluorescence and Nuclear Co-IP were performed as previously described (Ding et al., 2016) . Obtained fluorescence images were subjected to digital processing and background subtraction by Adobe Photoshop CS with identical conditions for each treatment group.
Histone Methyltransferase Activity Assay (H3K27)
Nuclear extraction was performed followed by histone methyltransferase activity ELISA assay according to the manufacturer's protocol (EpiGenTEK, OP-0002-1 and P-3005-48).
qPCR (Quantitative Polymerase Chain Reaction)
Total RNA was first isolated (Qiagen, 74, 104) and reverse transcribed according to the manufacturer's protocol (Thermo, K1642). cDNA was used for qPCR analysis with gene-specific primers and the reactions were detected using a FastStart Essential DNA Green Master (Roche, CA, 06402712001). The expression of mRNA was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. (GAPDH; △Cq = target mRNA Cq -GAPDH Cq). The individual primers used were listed below:
MLH1, forward, AAGCTCCTGGGCTCCAATTC MLH1, reverse, CGAGGTCAGACTTGTTGTGGA CDH1, forward, ATCCCACCACGTACAAGGGT CDH1, reverse, GTGTATACAGCCTCCCACGC GAPDH, forward, GAAGGTCGGAGTCAACGGATTT GAPDH, reverse, ATGGGTGGAATCATATTGGAC
Statistical Analysis
Relative densitometry, cell foci and qPCR data are presented as the mean AE standard error (SEM). These data are evaluated by one-way ANOVA with multiple comparisons and considered statistically significant with a P-value <.05. The number of replicates for each experiment is included in figure legends.
RESULTS
Oxidative Damage Induces Catalytic Activity-Dependent JAK2 Nuclear Translocation
In the canonical JAK2-STAT3 pathway, JAK2 becomes active, is autophosphorylated (p-JAK2 at Y1007/1008) and recruits STAT3 for phosphorylation (p-STAT3) in response to IL-6 stimulation (Wang and Sun, 2014) . While p-STAT3 translocates to the nucleus upon IL-6 treatment, activated JAK2 is retained in the cytoplasm by remaining bound to its receptor. To test if H 2 O 2 changes the subcellular localization of endogenous JAK2, nuclear and cytoplasmic fractions were isolated from untreated or treated human embryonic carcinoma (NCCIT) cells. In contrast to IL-6, H 2 O 2 treatment increases JAK2 protein levels in the nuclear fraction and decreases levels in the cytoplasmic fraction, as compared to untreated cells (Fig. 1A) . To confirm these results, experiments were repeated with a different JAK2 antibody. We demonstrated that both antibodies detect a band at the molecular weight of 131 kDa in whole cell extracts from nontarget knockdown (NT) NCCIT cells and this band is reduced in JAK2 knockdown cells with or without H 2 O 2 treatment, confirming the specificity of the two JAK2 antibodies (Supporting Information Fig. 1A ). To determine if JAK2 catalytic activity is important for JAK2 nuclear translocation, cells were treated with the JAK2 inhibitor Tyrphostin AG490 6 h prior to H 2 O 2 treatment and nuclear extractions were performed. Inhibiting JAK2 activity significantly reduces JAK2 and p-JAK2 nuclear localization (Fig. 1B) . In confirmation of the efficacy of the inhibitor, AG490 treatment reduces IL-6-induced levels of p-STAT3 (Fig. 1B) . Although Tyrphostin AG490 is a potent JAK2 inhibitor, it also nonspecifically inhibits other protein tyrosine kinases (Sayyah and Sayeski, 2009 ). Therefore, we used BMS-911543, a highly selective JAK2 inhibitor, to further validate our findings. At a nanomolar concentration BMS-911543 only inhibits the activity of JAK2 but not JAK1, JAK3, or SET-2 (Wan et al., 2015) . Inhibition of JAK2 by pretreatment with 2.2 nM BMS-911543 also reduces the H 2 O 2 -induced nuclear localization of JAK2 (Fig. 1C) . To further confirm JAK2 nuclear translocation, JAK2 subcellular localization was assessed by immunofluorescence. Low levels of JAK2 are present throughout the cell in untreated cells and cells treated with IL-6, whereas nuclear staining is detected after H 2 O 2 treatment (Fig. 1D) . Knockdown of JAK2 reduces oxidative damage-induced JAK2 signal in nuclei, suggesting this nuclear signal is JAK2 specific (Supporting Information Fig. 1B ). In confirmation of our western blot findings, inhibiting JAK2 catalytic activity with Tyrphostin AG490 abrogates the oxidative damage-induced nuclear localization of JAK2, suggesting JAK2 nuclear localization in response to oxidative damage is dependent on its catalytic activity.
Inhibition of JAK2 Alters Oxidative Damage-Induced Chromatin Binding of MSH6, MSH2, and DNMT1
Previously, it was demonstrated that MSH2 and MSH6 are predominantly localized in the cytoplasm basally but translocate into the nucleus and interact with DNMT1 in response to oxidative damage (Ding et al., 2016) . As we observed that oxidative damage also induces JAK2 nuclear translocation (Fig. 1A) , we initially hypothesized that nuclear localization of MSH2 and MSH6 after oxidative Environmental and Molecular Mutagenesis. DOI 10.1002/em damage may be dependent on JAK2. However, as demonstrated by protein levels in nuclear fractions (Supporting Information Fig. 2A ) from BMS911543 or Tyrphostin AG490 treated cells and nuclear inputs used for coimmunoprecipitation (co-IP) after Tyrphostin AG490 treatment (Supporting Information Fig. 3A and 3B ), JAK2 inhibition does not affect nuclear levels of MSH2, MSH6, or DNMT1 basally or in response to oxidative damage. By using a chromatin affinity assay that includes a high concentration salt buffer wash, we previously demonstrated that oxidative damage increases the affinity of MSH2, MSH6, and DNMT1 for chromatin (Ding et al., 2016) . In response to H 2 O 2 treatment, JAK2 also has increased affinity for chromatin ( Fig. 2A) . Importantly, inhibition of JAK2 by Tyrphostin AG490 reduces the H 2 O 2 -induced increase in affinity of MSH6, DNMT1 and JAK2 for Fig. 1 . Oxidative damage induces catalytic activity-dependent JAK2 nuclear localization.(A) Nuclear extractions were performed using NCCIT cells untreated or treated with 2 mM H 2 O 2 for 30 min or IL-6 (10 ng/mL) for 10 min. LaminB and GAPDH are nuclear and cytoplasmic controls, respectively. The data presented are from one representative experiment of two biological replicates. (B) Nuclear extractions were performed using NCCIT cells untreated or treated with 100 μM Tyrphostin AG490 for 6 h followed by 2 mM H 2 O 2 for 30 min or 10 ng/mL IL-6 treatment for 10 min. p-STAT3 serves as a control for treatments. Relative densitometry data are displayed as mean AE SEM for each treatment condition for JAK2 and p-JAK2 (n = 3). **P < .01, "ns" indicates not significant, P > .05. (C) Nuclear fractions were prepared from NCCIT cells untreated or treated with 2.2 nM BMS-911543 for 6 h followed by 30 min, 2 mM H 2 O 2 treatment. Relative densitometry data are displayed as mean AE SEM for each treatment condition (n = 3). *P < .05, "ns" indicates not significant, P > .05 (D) NCCIT cells were treated as in B followed by immunofluorescence analysis. Percentage of cells with nuclear JAK2 staining were quantified by counting five fields of view and displayed as mean AE SEM for each treatment condition (n = 3). **P < .01, "ns" indicates not significant, P > .05.
Environmental and Molecular Mutagenesis. DOI 10.1002/em chromatin. JAK2 inhibition prevents a statistically significant increase in affinity of MSH2 for chromatin after H 2 O 2 treatment when comparing untreated and H 2 O 2 -treated JAK2-inhibited samples. However, JAK2 inhibition does not significantly reduce the increase in affinity of MSH2 for chromatin in response to H 2 O 2 treatment as compared with H 2 O 2 treatment alone ( Fig. 2A) . This finding suggests that there may be an additional mechanism for H 2 O 2 -induced MSH2 chromatin binding, possibly through its interaction with MSH3 as part of MutSβ, which we have demonstrated occurs basally and after oxidative damage (Ding et al., 2016) . The total cellular levels of MSH2, MSH6, and DNMT1 are not affected by Tyrphostin AG490 or H 2 O 2 treatment ( Fig. 2A) . Moreover, inhibition of JAK2 by Tyrphostin AG490 increases the level of γH2AX basally and after oxidative damage ( Fig. 2A) , consistent with a previous report that JAK2 activation causes an increase in homologous recombination (Gloc et al., 2002) . Consistent with the effect of Tyrphostin AG490, inhibition of JAK2 by BMS-911543 reduces the H 2 O 2 -induced increase in affinity of MSH6, MSH2, DNMT1, and JAK2 for chromatin (Fig. 2B) . BMS-911543 treatment reduces oxidative damage-induced levels of p-STAT3 (Fig. 2B) , confirming the efficacy of the inhibitor. There is a trend for an increase of γH2AX levels in response to BMS911543 treatment basally and after oxidative damage, but this change is not significant (Fig. 2B) . To confirm these findings, binding of MSH2, MSH6 and DNMT1 to chromatin following knockdown of JAK2 by lentiviral shRNA was analyzed. Knockdown of JAK2 reduces oxidative damage-induced chromatin binding of MSH6 and DNMT1 without affecting total protein levels of MSH6 or DNMT1 (Fig. 2C) . Again, there is a trend for reduction in affinity for MSH2, but this change is not significant (Fig. 2C) . Consistent with our previous results (Ding et al., 2016) , knockdown of MSH6 reduces oxidative damageinduced chromatin interaction of MSH6 and DNMT1 but does not affect total protein level of DNMT1 (Fig. 2C) .
Immunofluorescence can also be used to interrogate DNMT1's response to oxidative damage because oxidative damage induces DNMT1 foci that co-localize with the DNA damage marker γH2AX (Ding et al., 2016; Supporting Information Fig. 2B ). Inhibition or knockdown of JAK2 abrogates the formation of oxidative damage-induced DNMT1 foci and the co-localization between DNMT1 and γH2AX (Supporting Information Fig. 2B and 2C ). Consistent with the western blot results ( Fig. 2A,B) , inhibition or knockdown of JAK2 elevates levels of γH2AX basally and after oxidative damage in immunofluorescence analysis (Supporting Information Fig. 2B and 2C) .
Besides JAK2 oxidative damage also activates several other protein kinases such as protein kinase C (PKC), protein kinase B (PKB or AKT), Jun N-terminal kinases (JNK), mitogen-activated protein kinase (MAPK; Martindale and Holbrook, 2002 In response to H 2 O 2 treatment, MSH6, MSH2, DNMT1, and JAK2 concordantly have increased affinity for chromatin ( Fig. 2A) . We hypothesized that nuclear JAK2 interacts with one or multiple of these proteins and therefore cytoplasmic and nuclear Co-IPs were performed to study the protein-protein interactions in different cellular compartments. Previously we have demonstrated that MSH2 and MSH6 primarily localize in the cytoplasm in the basal state in NCCIT cells (Ding et al., 2016) . Here, we demonstrate that MSH2 interacts with JAK2 and MSH6 in the untreated state in the cytoplasm (Fig. 3A) . In response to oxidative damage, the interaction of MSH2 with MSH6 in the cytoplasm is reduced and there is no detectable JAK2 in the cytoplasm (Fig. 3A) . In response to H 2 O 2 treatment, levels of MSH2, MSH6 and JAK2 in the nuclear input fraction are increased consistent with their nuclear translocation ( Fig. 3B-D) ; whereas DNMT1and EZH2 are unchanged. JAK2 interacts with MSH2 and MSH6 in nuclear fractions in response to H 2 O 2 , whereas no interaction is detected in untreated cells (Fig. 3B) . No interaction is detected between nuclear JAK2 and epigenetic proteins, including DNMT1, EZH2, SUZ12, or EED2 basally or in response to H 2 O 2 ( Fig. 3B and data not shown) . Nuclear Co-IPs using antibodies against MSH2 and MSH6 confirm their interaction with JAK2 in the nucleus after H 2 O 2 treatment (Fig. 3C,D) . Together, these findings demonstrate that MSH2 interacts with JAK2 basally in the cytoplasm and oxidative damage induces the nuclear translocation of MSH2, MSH6, and JAK2 resulting in their interaction in the nucleus.
Inhibition of JAK2 Alters the PRC2 Response to Oxidative Damage
Previously, we have demonstrated that oxidative damage induces the DNMT1-dependent interaction of MSH2 and MSH6 with PRC2 members, EZH2, SUZ12, and EED2 (O'Hagan et al., 2011; Ding et al., 2016) . Because inhibition of JAK2 alters the interaction of DNMT1 with chromatin, it may also affect the chromatin affinity of PRC2 members. Interestingly, although H 2 O 2 alone does not increase the affinity of EZH2 and EED for chromatin, inhibition of JAK2 by Tyrphostin AG490 or BMS-911543 significantly reduces EZH2 and EED2 chromatin affinity after H 2 O 2 treatment (Fig. 4A,B) . After H 2 O 2 treatment, there is a trend for reduction in affinity for SUZ12 with inhibition of JAK2 by either Environmental and Molecular Mutagenesis. DOI 10.1002/em Tyrphostin AG490 or BMS-911543, but the effect of Tyrphostin AG490 is not significant (Fig. 4A,B) . These results were further validated in the SW480 colon cancer cell line (Supporting Information Fig. 4A ). To test if JAK2 alters the protein-protein interactions between MSH6, DNMT1 and PRC2, nuclear Co-IPs were performed using antibodies against MSH6 or EZH2 in cells where JAK2 was inhibited followed by 30 min H 2 O 2 treatment. JAK2 inhibition does not alter the oxidative damage-induced interaction of MSH6, DNMT1, and PRC2 (Supporting Information Fig. 3A and 3B).
The finding that JAK2 alters the chromatin interaction of PRC2 members in response to oxidative damage suggests a potential functional role for JAK2 in regulating the level of H3K27me3 after oxidative damage. As previously demonstrated, 3 h after H 2 O 2 treatment, there is a global increase Chromatin affinity assays were performed using NCCIT cells untreated or treated with 100 μM Tyrphostin AG490 for 6 h followed by 30 min, 2 mM H 2 O 2 treatment. Tight chromatin is the remaining protein in the chromatin pellet after extraction with 0.45 M NaCl buffer. Relative densitometry data are displayed as mean AE SEM for each treatment condition (n = 3). *P < .05, **P < .01, "ns" indicates not significant, P > .05. (B) NCCIT cells were untreated or treated with 2.2 nM BMS-911543 for 6 h followed by 30 min, 2 mM H 2 O 2 treatment. Chromatin affinity assays and whole cell lysate extractions are performed. Relative densitometry data are displayed as mean AE SEM for each treatment condition (n = 3). *P < .05, **P < .01, "ns" indicates not significant, P > .05. (C) NCCIT cells were infected with nontarget (NT), or JAK2 shRNA lentiviral particles. After 96 h, they were untreated or treated with 2 mM H 2 O 2 for 30 min. Chromatin affinity assays and whole cell lysate extractions were performed. Relative densitometry data are displayed as mean AE SEM for each treatment condition (n = 3). *P < .05, **P < .01, "ns" indicates not significant, P > .05.
Environmental and Molecular Mutagenesis. DOI 10.1002/em of H3K27me3 (Niu et al., 2015) . Knockdown of JAK2 significantly reduces oxidative damage-induced H3K27me3 levels (Fig. 4C) . H 2 O 2 can alter the catalytic activity of enzymes (Rhee et al., 2000 ) and EZH2's activity can be altered by post-translational modifications (Karantanos and Boussiotis, 2016) . However, neither JAK2 knockdown nor H 2 O 2 treatment alters the H3K27me3 histone methyltransferase activity in cellular lysates compared to basal NT cells (Supporting Information Fig. 4B) .
Oxidative damage causes a transient reduction in transcription of CpG island containing genes, including the TSGs CDH1 (Cadherin1 or E-cadherin) and MLH1 (MutL homolog 1) that commonly undergo gene silencing and promoter CpG island hypermethylation in colorectal cancer (Wheeler et al., 2001; Li et al., 2013) . This reduction in transcription is dependent on the MSH2/6-mediated recruitment of epigenetic proteins to chromatin (Ding et al., 2016) . Consistent with these results, H 2 O 2 treatment leads to a reduction in gene expression of CDH1 and MLH1 in SW480 cells and JAK2 inhibition significantly abrogates this reduction in transcription (Fig. 4D) . Altogether, these findings suggest that JAK2 regulates oxidative damage-induced global changes in H3K27me3 and transcription of candidate TSGs through altering the interaction of MSH2/MSH6, DNMT1, and PRC2 member proteins with chromatin.
JAK2 Expression Is Associated with CIMP in Human Colorectal Cancer
Cancer-specific aberrant gains in DNA methylation tend to occur at gene promoters enriched for H3K27me3 (Schlesinger et al., 2007; Rose and Klose, 2014) . In humans, tumors bearing a high frequency of occurrence of aberrant promoter CpG island DNA hypermethylation are defined as CIMP-high (CIMP-H), whereas tumors bearing lower frequency or minimal CpG island hypermethylation are referred to as CIMP-L or non-CIMP, respectively. CIMP positive status is associated with poor prognosis and worse treatment outcome than non-CIMP status in colorectal cancer patients (Van Rijnsoever et al., 2003) . Having demonstrated JAK2 is important for the recruitment of DNMT1 to sites of damage and global induction of H3K27me3, we next examined if JAK2 is associated with aberrant DNA hypermethylation in colorectal cancer, using CIMP status as a surrogate marker for promoter CpG island hypermethylation. In JAK2 RNA-seq data and CIMP status obtained from the TCGA colorectal cancer database (The Cancer Genome Atlas, COADREAD; The Cancer Genome Atlas Network, 2012), CIMP-H status correlates with higher expression of JAK2 mRNA, whereas CIMP-L or non-CIMP (Cluster 3 and 4) cancers have lower gene expression of JAK2 (Fig. 5) , suggesting JAK2 expression is closely associated with promoter CpG island methylation in colorectal cancer.
DISCUSSION
Recent studies demonstrate that kinases activated by cellular stress can alter the function of epigenetic proteins, leading to increased epigenetic regulation in cells (Cha et al., 2005; Kim et al., 2013) . In the present study, we link the oxidative damage-induced activation and nuclear localization of JAK2 to the enrichment of MMR and epigenetic Environmental and Molecular Mutagenesis. DOI 10.1002/em silencing proteins on damaged chromatin. This response is associated with changes in global levels of H3K27me3, and transcriptional repression of candidate TSGs in cancer. Furthermore, JAK2 mRNA expression is closely associated with CIMP-H status in colorectal cancer. While it is well known that constitutive activation of JAK2 can induce neoplastic transformation and cancer progression by activating downstream STAT proteins and promoting oncogenic transcription in hematopoietic malignancies (Vainchenker et al., 2008) , much less is known regarding noncanonical roles of nuclear JAK2 in solid tumors. The role of JAK2 activity and noncanonical nuclear localization in the MMR and epigenetic responses to oxidative damage potentially links JAK2 to tumor progression in a novel way.
JAK2 is canonically studied as a cytoplasmic protein that is bound to a receptor and transmits information in response to ligand binding to the receptor to effect downstream gene transcription. In this study, we identified a noncanonical role of JAK2 in response to oxidative damage in human cells that is uncoupled from its role in the classic, Fig. 4 . Inhibiting JAK2 alters the PRC2 response to oxidative damage. (A) Chromatin affinity assays were performed using NCCIT cells untreated or treated with 100 μM Tyrphostin AG490 for 6 h followed by 30 min, 2 mM H 2 O 2 treatment. * indicates EED2. Relative densitometry data are displayed as mean AE SEM for each treatment condition for EZH2, SUZ12, and EED2 (n = 3). *P < .05, "ns" indicates not significant, P > .05. ND indicates signal is not detected. (B) Chromatin affinity assays were performed using NCCIT cells untreated or treated with 2.2 nM BMS-911543 for 6 h followed by 30 min, 2 mM H 2 O 2 treatment. * indicates EED2. Relative densitometry data are displayed as mean AE SEM for each treatment condition for EZH2, SUZ12, and EED2 (n = 3). *P < .05, *P < .01, "ns" indicates not significant, P > .05. ND indicates signal is not detected. (C) Whole cell lysate was collected from NCCIT cells infected with nontarget (NT), or JAK2 shRNA lentiviral particles for 96 h followed by 3 h, 0.25 mM H 2 O 2 treatment. Relative densitometry data are displayed as mean AE SEM for each treatment condition for H3K27me3 (n = 3). *P < .05, **P < .01, "ns" indicates not significant, P > .05. (D) SW480 cells were untreated or treated with 100 μM Tyrphostin AG490 for 6 h followed by 3-h, 0.5 mM H 2 O 2 treatment. Total RNA was isolated and RT-qPCR is performed. Relative fold change displayed as mean AE SEM of H 2 O 2 treated over untreated (n = 3). *P < .05, **P < .01.
ligand-dependent pathway. We demonstrate that in response to oxidative damage, JAK2 can localize to the nucleus, while activation of JAK2 in a canonical manner by IL-6 treatment does not induce such a change. This finding indicates that oxidative damage may employ different mechanisms from IL-6 to activate JAK2, possibly through oxidizing and inhibiting JAK2's negative regulator-protein tyrosine phosphatases (PTPs), including cluster of differentiation 45 (CD45) and Src homology region 2 domaincontaining phosphatase-1 (SHP1; Oh et al., 2009) . JAK2 is basally inhibited and dephosphorylated at Y1007/1008 by PTPs . ROS induce thiol oxidation in the catalytic sites of PTPs and this modification permits release of JAK2 from the PTPs, resulting in activation of JAK2 (Knobler and Elson, 2014; Oh et al., 2009) . In line with these findings, we connect JAK2 nuclear translocation to its activity by demonstrating that inhibition of JAK2 induces dephosphorylation of JAK2 at Y1007/1008 and reduces oxidative damage-induced nuclear localization of JAK2. Further supporting the role of JAK2 phosphorylation in mediating JAK2 nuclear translocation, the JAK2 kinasedead mutant K882E shows basally low nuclear localization signal, whereas the constitutively active JAK2 V617F has high nuclear localization signal (Sedek and Strous, 2013) .
Epigenetic proteins are involved in the DNA damage response and it is hypothesized that DNA repair pathways recruit epigenetic proteins to assist in the DNA repair process. The role of epigenetic proteins in DNA repair has been described by the "access-repair-restore" model (Green and Almouzni, 2002; Ding et al., 2017) . In response to damage, "active" chromatin modifiers such as histone acetyltransferases (HATs) and chromatin remodeling complexes are first recruited to the sites of DNA damage to "open" local chromatin structure allowing DNA repair proteins to gain access. Once DNA repair proteins access DNA, "repressive" chromatin modifiers such as histone deacetylases (HDACs) are recruited to "close" the chromatin and repress transcriptional activity. Finally, chromatin is restored back to its original state when repair is completed (Ding et al., 2017) . In response to oxidative DNA damage, we demonstrated that (1) JAK2 is recruited to chromatin, (2) JAK2 interacts with MSH2 and MSH6 in the nucleus, and (3) inhibiting JAK2 alters the chromatin interaction of MSH2, MSH6, DNMT1, and PRC2 members. JAK2 inhibition or knockdown does not alter oxidative damageinduced nuclear localization of MSH2 and MSH6 suggesting that the increased chromatin association of MSH2 and MSH6 in response to oxidative damage is not through their increased nuclear localization. Based on these results, we hypothesize that in response to oxidative damage, JAK2 recruits MSH2 and MSH6 to promoter CpG islands that contain clustered oxidative damage as a result of preferential oxidative damage of guanines. Previous studies demonstrated that constitutively active mutant JAK2 acts as an "active" chromatin modifier, which can directly interact and phosphorylate histone H3 at Y41 (H3Y41ph) to promote downstream transcription (Dawson et al., 2009) . The H3Y41ph mark is associated with transcriptional activity and is primarily present at promoter transcription start sites (TSS) of active genes. Importantly, inhibition of JAK2 significantly reduces H3Y41ph at the TSS of genes (Dawson et al., 2012) . We hypothesize that in response to oxidative damage, JAK2 is recruited to chromatin to mediate chromatin-based changes at damaged promoters and these changes facilitate DNA repair. The association of JAK2 with active chromatin may first open up local chromatin structure to allow MSH2 and MSH6 to gain access to clustered oxidative DNA damage. After accessing the damage, MSH2 and MSH6 recruit "repressive" epigenetic proteins including DNMT1 and PRC2 members to sites of damage. This recruitment results in a transient reduction in transcription so that transcription does not interfere with the DNA repair (Ding et al., 2016) . An alternative hypothesis is that JAK2 may regulate the chromatin interaction of MSH2 and MSH6 through phosphorylation of MSH2 and/or MSH6. There are known phosphorylation events Environmental and Molecular Mutagenesis. DOI 10.1002/em that alter the MMR response to DNA damage. For example, MSH2 can be phosphorylated by the tyrosine kinase NPM-ALK in a manner that inhibits dimerization of MSH2 with MSH6 (Bone et al., 2015) . We immunoprecipitated MSH2 and MSH6 from nuclear extracts from both untreated and H 2 O 2 treated NCCIT cells and performed LC-MS/MS tandem mass spectrometry in an effort to identify tyrosine phosphorylation modifications on MSH2 and MSH6, but were unable to detect these modifications. Because of the known difficulty in detecting tyrosine phosphorylation on large proteins by mass spectrometry, we cannot rule out the possibility that JAK2's regulation of MSH2 and MSH6 is through a phosphorylation event. Further studies on how JAK2 increases the affinity of MSH2 and MSH6 for chromatin in response to oxidative damage are needed.
Our findings suggest one potential mechanism for the initiation of abnormal silencing of TSGs during tumorigenesis. We provide a novel link between JAK2, recruitment of repressive proteins and transient loss of gene expression in response to oxidative damage. JAK2 signaling is well known for its function upstream of transcriptional activation of genes that are responsible for growth and proliferation. However, the findings presented here uniquely suggest that oxidative damage-induced nuclear JAK2 regulates chromatin enrichment of DNA repair proteins, epigenetic silencing proteins, and H3K27me3, thereby facilitating repression of candidate TSGs. JAK2 may also be linked to aberrant promoter CpG island DNA hypermethylation seen in human cancers. The JAK2-dependency of enhanced binding of DNMT1 to chromatin in response to oxidative damage, suggests that JAK2 is important for aberrant DNMT1 targeting during DNA damage. Recruitment of DNMT1 to sites of damage can result in sustained, aberrant DNA methylation of gene promoters both in vitro and in vivo (O'Hagan et al., 2008; Maiuri et al., 2017) . In line with these results, we demonstrate that JAK2 mRNA expression is associated with CIMP status in colorectal cancer. Together these results suggest JAK2 may participate in the initiation of aberrant DNA methylation during chronic inflammation.
Epigenetic therapy such as treatment with DNMT inhibitors azacytidine and decitabine is currently recommended to treat high risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). DNMT inhibitors are also currently being used to treat solid tumors in clinical trials. Despite their promising clinical future, success of these agents may depend on the durability of the DNA demethylation induced by them (Kagey et al., 2010) . Azacytidine treatment of cells in vitro effectively reverses DNA hypermethylation. However, after removing azacytidine from the cells, genes reaccumulate promoter DNA hypermethylation over time (McGarvey et al., 2006) . This result is possibly due to the fact that azacytidine only alters DNA methylation but does not alter the low levels of repressive chromatin marks, including H3K27me3 that are present at these promoters (McGarvey et al., 2006) . This may be critical, as retention of H3K27me3 is known to recruit DNMTs and induce DNA methylation (McGarvey et al., 2006) . Inhibition of JAK2 by Tyrphostin AG490 or BMS-911543 results in reduced binding of DNMT1 and PRC2 members to chromatin, which may result in reduction of H3K27me3 deposition on genes during inflammation and carcinogenesis and reduce their resilencing after azacytidine treatment is stopped. However, whether JAK2 inhibition affects resilencing of aberrantly DNA hypermethylated genes requires further study and validation. In addition, inhibiting JAK2 by BMS-911543 is shown to be safe, well tolerated in human, and this inhibitor is currently in clinical trials for treatment of myelofibrosis (Roberts et al., 2013) . While further studies are required, nuclear JAK2 may be a potential target for the development of additional therapeutics for inflammation-driven cancers.
In summary, we demonstrate that in response to oxidative damage, JAK2 is activated and translocates into the nucleus where it plays a key role in regulating MSH2 and MSH6 binding to damaged chromatin. Through its regulation of MSH2 and MSH6, JAK2 also affects oxidativedamage induced increases in DNMT1 and EZH2 chromatin affinity, chromatin modifications and changes in gene expression of candidate TSGs. Furthermore, we demonstrate that JAK2 mRNA expression is closely correlated with CIMP status in human colorectal cancer.
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